108 related articles for article (PubMed ID: 28739384)
1. Tumor heterogeneity determined with a γH2AX foci assay: A study in human head and neck squamous cell carcinoma (hHNSCC) models.
Rassamegevanon T; Löck S; Range U; Krause M; Baumann M; von Neubeck C
Radiother Oncol; 2017 Sep; 124(3):379-385. PubMed ID: 28739384
[TBL] [Abstract][Full Text] [Related]
2. Residual gammaH2AX foci in head and neck squamous cell carcinomas as predictors for tumour radiosensitivity: Evaluation in pre-clinical xenograft models and clinical specimens.
Meneceur S; Löck S; Gudziol V; Hering S; Bütof R; Rehm M; Baumann M; Krause M; von Neubeck C
Radiother Oncol; 2019 Aug; 137():24-31. PubMed ID: 31048234
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of γH2AX Foci Increases in Ex Vivo Biopsies Relative to In Vivo Tumors.
Rassamegevanon T; Löck S; Baumann M; Krause M; von Neubeck C
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30181446
[TBL] [Abstract][Full Text] [Related]
4. Comparable radiation response of ex vivo and in vivo irradiated tumor samples determined by residual γH2AX.
Rassamegevanon T; Löck S; Baumann M; Krause M; von Neubeck C
Radiother Oncol; 2019 Oct; 139():94-100. PubMed ID: 31445839
[TBL] [Abstract][Full Text] [Related]
5. γH2AX assay in ex vivo irradiated tumour specimens: A novel method to determine tumour radiation sensitivity in patient-derived material.
Menegakis A; von Neubeck C; Yaromina A; Thames H; Hering S; Hennenlotter J; Scharpf M; Noell S; Krause M; Zips D; Baumann M
Radiother Oncol; 2015 Sep; 116(3):473-9. PubMed ID: 25866027
[TBL] [Abstract][Full Text] [Related]
6. Residual γH2AX foci predict local tumour control after radiotherapy.
Koch U; Höhne K; von Neubeck C; Thames HD; Yaromina A; Dahm-Daphi J; Baumann M; Krause M
Radiother Oncol; 2013 Sep; 108(3):434-9. PubMed ID: 23891089
[TBL] [Abstract][Full Text] [Related]
7. Changes in the fraction of total hypoxia and hypoxia subtypes in human squamous cell carcinomas upon fractionated irradiation: evaluation using pattern recognition in microcirculatory supply units.
Maftei CA; Bayer C; Shi K; Astner ST; Vaupel P
Radiother Oncol; 2011 Oct; 101(1):209-16. PubMed ID: 21641070
[TBL] [Abstract][Full Text] [Related]
8. Prediction of clonogenic cell survival curves based on the number of residual DNA double strand breaks measured by gammaH2AX staining.
Menegakis A; Yaromina A; Eicheler W; Dörfler A; Beuthien-Baumann B; Thames HD; Baumann M; Krause M
Int J Radiat Biol; 2009 Nov; 85(11):1032-41. PubMed ID: 19895280
[TBL] [Abstract][Full Text] [Related]
9. The extreme radiosensitivity of the squamous cell carcinoma SKX is due to a defect in double-strand break repair.
Kasten-Pisula U; Menegakis A; Brammer I; Borgmann K; Mansour WY; Degenhardt S; Krause M; Schreiber A; Dahm-Daphi J; Petersen C; Dikomey E; Baumann M
Radiother Oncol; 2009 Feb; 90(2):257-64. PubMed ID: 19038467
[TBL] [Abstract][Full Text] [Related]
10. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation.
Yaromina A; Krause M; Thames H; Rosner A; Krause M; Hessel F; Grenman R; Zips D; Baumann M
Radiother Oncol; 2007 Jun; 83(3):304-10. PubMed ID: 17517444
[TBL] [Abstract][Full Text] [Related]
11. Lack of a correlation between γH2AX foci kinetics in lymphocytes and the severity of acute normal tissue reactions during IMRT treatment for head and neck cancer.
Werbrouck J; Duprez F; De Neve W; Thierens H
Int J Radiat Biol; 2011 Jan; 87(1):46-56. PubMed ID: 21142613
[TBL] [Abstract][Full Text] [Related]
12. Residual DNA double strand breaks in perfused but not in unperfused areas determine different radiosensitivity of tumours.
Menegakis A; Eicheler W; Yaromina A; Thames HD; Krause M; Baumann M
Radiother Oncol; 2011 Jul; 100(1):137-44. PubMed ID: 21821302
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo γH2AX radiation sensitivity assay in prostate cancer: Inter-patient and intra-patient heterogeneity.
De-Colle C; Yaromina A; Hennenlotter J; Thames H; Mueller AC; Neumann T; Stenzl A; Scharpf M; Fend F; Ricardi U; Baumann M; Zips D; Menegakis A
Radiother Oncol; 2017 Sep; 124(3):386-394. PubMed ID: 28919005
[TBL] [Abstract][Full Text] [Related]
14. Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET for detecting tumor repopulation during fractionated radiotherapy of human FaDu squamous cell carcinoma in nude mice.
Yue JB; Yang J; Liu J; Lee J; Cabrera AR; Sun XD; Bai GH; Li YH; Yu JM
Radiother Oncol; 2014 Jun; 111(3):475-81. PubMed ID: 24813091
[TBL] [Abstract][Full Text] [Related]
15. AC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivo.
Torres MA; Raju U; Molkentine D; Riesterer O; Milas L; Ang KK
Invest New Drugs; 2011 Aug; 29(4):554-61. PubMed ID: 20119866
[TBL] [Abstract][Full Text] [Related]
16. Effect of [(18)F]FMISO stratified dose-escalation on local control in FaDu hSCC in nude mice.
Schütze C; Bergmann R; Brüchner K; Mosch B; Yaromina A; Zips D; Hessel F; Krause M; Thames H; Kotzerke J; Steinbach J; Baumann M; Beuthien-Baumann B
Radiother Oncol; 2014 Apr; 111(1):81-7. PubMed ID: 24636842
[TBL] [Abstract][Full Text] [Related]
17. Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations.
Zumsteg ZS; Morse N; Krigsfeld G; Gupta G; Higginson DS; Lee NY; Morris L; Ganly I; Shiao SL; Powell SN; Chung CH; Scaltriti M; Baselga J
Clin Cancer Res; 2016 Apr; 22(8):2009-19. PubMed ID: 26589432
[TBL] [Abstract][Full Text] [Related]
18. The Effects of Pulsed Radiation Therapy on Tumor Oxygenation in 2 Murine Models of Head and Neck Squamous Cell Carcinoma.
Wobb J; Krueger SA; Kane JL; Galoforo S; Grills IS; Wilson GD; Marples B
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):820-8. PubMed ID: 26104936
[TBL] [Abstract][Full Text] [Related]
19. Measurement of reoxygenation during fractionated radiotherapy in head and neck squamous cell carcinoma xenografts.
Harriss W; Bezak E; Yeoh E; Hermans M
Australas Phys Eng Sci Med; 2010 Sep; 33(3):251-63. PubMed ID: 20878297
[TBL] [Abstract][Full Text] [Related]
20. Residual γH2AX foci after ex vivo irradiation of patient samples with known tumour-type specific differences in radio-responsiveness.
Menegakis A; De Colle C; Yaromina A; Hennenlotter J; Stenzl A; Scharpf M; Fend F; Noell S; Tatagiba M; Brucker S; Wallwiener D; Boeke S; Ricardi U; Baumann M; Zips D
Radiother Oncol; 2015 Sep; 116(3):480-5. PubMed ID: 26297183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
